Transcriptional regulation of bidirectional gene pairs by 17 beta-estradiol in MCF-7 breast cancer cells
Carregando...
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRAS DIVULG CIENTIFICA
Autores
Citação
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, v.44, n.2, p.112-122, 2011
Resumo
Using cDNA microarray analysis, we previously identified a set of differentially expressed genes in primary breast tumors based on the status of estrogen and progesterone receptors. In the present study, we performed an integrated computer-assisted and manual search of potential estrogen response element (ERE) binding sites in the promoter region of these genes to characterize their potential to be regulated by estrogen receptors (ER). Publicly available databases were used to annotate the position of these genes in the genome and to extract a 5' flanking region 2 kb upstream to 2 kb downstream of the transcription start site for transcription binding site analysis. The search for EREs and other binding sites was performed using several publicly available programs. Overall, approximately 40% of the genes analyzed were potentially able to be regulated by estrogen via ER. In addition, 17% of these genes are located very close to other genes organized in a head-to-head orientation with less than 1.0 kb between their transcript units, sharing a bidirectional promoter, and could be classified as bidirectional gene pairs. Using quantitative real-time PCR, we further investigated the effects of 17 beta-estradiol and antiestrogens on the expression of the bidirectional gene pairs in MCF-7 breast cancer cells. Our results showed that some of these gene pairs, such as TXNDC9/EIF5B, GALNS/TRAPPC2L, and SERINC1/PKIB, are modulated by 17 beta-estradiol via ER in MCF-7 breast cancer cells. Here, we also characterize the promoter region of potential ER-regulated genes and provide new information on the transcriptional regulation of bidirectional gene pairs.
Palavras-chave
Breast cancer, Estrogen receptor, Gene expression, Bidirectional promoters
Referências
- Anderson I, 2000, BIOCHEMISTRY-US, V39, P3842, DOI 10.1021/bi9924516
- Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407
- Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028
- Santos EDS, 2008, INT J ONCOL, V33, P25
- Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4
- Medina D, 2005, ENDOCR-RELAT CANCER, V12, P483, DOI 10.1677/erc.1.00804
- Takai D, 2004, MOL BIOL EVOL, V21, P463, DOI 10.1093/molbev/msh040
- Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008
- Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006
- Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008
- Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4
- Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200
- Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005
- Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569
- Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014
- Petz LN, 2004, J STEROID BIOCHEM, V88, P113, DOI 10.1016/j.jsbmb.2003.11.008
- Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804
- Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334
- Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905
- Sathya G, 1997, MOL ENDOCRINOL, V11, P1994, DOI 10.1210/me.11.13.1994
- O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044
- Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441
- Aumais JP, 1996, J BIOL CHEM, V271, P12568
- Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3605, DOI 10.1093/nar/gkg517
- Bellizzi D, 2007, GENOMICS, V89, P143, DOI 10.1016/j.ygeno.2006.09.004
- Chen PY, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-2
- CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
- Collins PJ, 2007, PLOS GENET, V3, P2247, DOI 10.1371/journal.pgen.0030208
- Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074
- Nagai MA, 2004, INT J CANCER, V111, P892, DOI 10.1002/ijc.20329
- Nakagawa H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001484
- Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629
- Tsai HK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-352
- Vega Vinsensius B, 2006, Genome Biol, V7, pR82, DOI 10.1186/gb-2006-7-9-r82
- Voth H, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-28
- Yang MQ, 2007, PLOS COMPUT BIOL, V3, P733, DOI 10.1371/journal.pcbi.0030072
- Yang MQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S3
- Yang MQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S2
- Yang MQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S9
- Zanotto E, 2007, NUCLEIC ACIDS RES, V35, P664, DOI 10.1093/nar/gkl1037